drugset / Trial / NCT02603068
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
RandomizedParallel-groupOpen-labelTreatment
Summary
This multicenter, randomized, open-label study will assess the safety and efficacy of oral treprostinil in subjects diagnosed with pulmonary hypertension associated with pulmonary fibrosis.
Timeline
- Start
- 2016-02
- Primary completion
- 2018-04
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 1 mg | Oral |
| Subject | Treprostinil | Other / unclassified | 12 mg | Oral |